Literature DB >> 26098696

Evaluating efficiency and statistical power of self-controlled case series and self-controlled risk interval designs in vaccine safety.

Rongxia Li1, Brock Stewart1, Eric Weintraub1.   

Abstract

The self-controlled case series (SCCS) and self-controlled risk interval (SCRI) designs have recently become widely used in the field of post-licensure vaccine safety monitoring to detect potential elevated risks of adverse events following vaccinations. The SCRI design can be viewed as a subset of the SCCS method in that a reduced comparison time window is used for the analysis. Compared to the SCCS method, the SCRI design has less statistical power due to fewer events occurring in the shorter control interval. In this study, we derived the asymptotic relative efficiency (ARE) between these two methods to quantify this loss in power in the SCRI design. The equation is formulated as [Formula: see text] (a: control window-length ratio between SCRI and SCCS designs; b: ratio of risk window length and control window length in the SCCS design; and [Formula: see text]: relative risk of exposed window to control window). According to this equation, the relative efficiency declines as the ratio of control-period length between SCRI and SCCS methods decreases, or with an increase in the relative risk [Formula: see text]. We provide an example utilizing data from the Vaccine Safety Datalink (VSD) to study the potential elevated risk of febrile seizure following seasonal influenza vaccine in the 2010-2011 season.

Entities:  

Keywords:  Febrile seizure; Vaccine Safety Datalink; observational data; study design

Mesh:

Substances:

Year:  2015        PMID: 26098696     DOI: 10.1080/10543406.2015.1052819

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  9 in total

1.  Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.

Authors:  James G Donahue; Burney A Kieke; Edwin M Lewis; Eric S Weintraub; Kayla E Hanson; David L McClure; Elizabeth R Vickers; Julianne Gee; Matthew F Daley; Frank DeStefano; Rulin C Hechter; Lisa A Jackson; Nicola P Klein; Allison L Naleway; Jennifer C Nelson; Edward A Belongia
Journal:  Pediatrics       Date:  2019-11-18       Impact factor: 7.124

2.  Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines.

Authors:  Shirley V Wang; Abdurrahman Abdurrob; Julia Spoendlin; Edwin Lewis; Sophia R Newcomer; Bruce Fireman; Matthew F Daley; Jason M Glanz; Jonathan Duffy; Eric S Weintraub; Martin Kulldorff
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-13       Impact factor: 2.890

3.  Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010-2018.

Authors:  Tara C Anderson; Jessica W Leung; Rafael Harpaz; Kathleen L Dooling
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

4.  Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.

Authors:  Caroline Korves; Hector S Izurieta; Jeremy Smith; Gabrielle M Zwain; Ethan I Powell; Abirami Balajee; Kathryn M Ryder; Yinong Young-Xu
Journal:  Vaccine       Date:  2022-06-21       Impact factor: 4.169

5.  Immune checkpoint inhibitors for cancer and venous thromboembolic events.

Authors:  Jingyi Gong; Zsofia D Drobni; Raza M Alvi; Sean P Murphy; Ryan J Sullivan; Sarah E Hartmann; Hannah K Gilman; Hang Lee; Leyre Zubiri; Vineet K Raghu; Rebecca S Karp-Leaf; Amna Zafar; Daniel A Zlotoff; Matthew J Frigault; Kerry L Reynolds; Tomas G Neilan
Journal:  Eur J Cancer       Date:  2021-10-15       Impact factor: 10.002

6.  Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.

Authors:  Silvia Perez-Vilar; Daniel Weibel; Miriam Sturkenboom; Steven Black; Christine Maure; Jose Luis Castro; Pamela Bravo-Alcántara; Caitlin N Dodd; Silvana A Romio; Maria de Ridder; Swabra Nakato; Helvert Felipe Molina-León; Varalakshmi Elango; Patrick L F Zuber
Journal:  Vaccine       Date:  2017-05-27       Impact factor: 3.641

7.  Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review.

Authors:  Yonatan Moges Mesfin; Allen Cheng; Jock Lawrie; Jim Buttery
Journal:  BMJ Glob Health       Date:  2019-07-08

8.  Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.

Authors:  Dongwon Yoon; Ji-Ho Lee; Hyesung Lee; Ju-Young Shin
Journal:  BMJ       Date:  2021-01-29

9.  Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19.

Authors:  Jessica M Franklin; Kueiyu Joshua Lin; Nicolle M Gatto; Jeremy A Rassen; Robert J Glynn; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2021-02-28       Impact factor: 6.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.